Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
China
· Delayed Price · Currency is CNY 18.42
+0.20 (1.10%)
Mar 10, 2026, 10:45 AM CST
SHE:002317 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 15,486 | 10,279 | 13,607 | 21,822 | 9,641 | 8,853 | Upgrade
|
| Market Cap Growth | 60.28% | -24.46% | -37.64% | 126.34% | 8.90% | -13.23% | Upgrade
|
| Enterprise Value | 14,736 | 8,899 | 12,528 | 21,472 | 9,286 | 8,358 | Upgrade
|
| Last Close Price | 18.22 | 11.96 | 15.58 | 25.88 | 11.45 | 10.20 | Upgrade
|
| PE Ratio | - | - | 51.69 | 67.76 | 34.73 | - | Upgrade
|
| Forward PE | - | 16.57 | 16.57 | 16.57 | 16.57 | 21.50 | Upgrade
|
| PS Ratio | 6.33 | 4.17 | 5.21 | 8.15 | 3.97 | 4.67 | Upgrade
|
| PB Ratio | 3.75 | 2.56 | 3.01 | 5.72 | 2.73 | 2.44 | Upgrade
|
| P/TBV Ratio | 4.42 | 2.87 | 3.68 | 6.75 | 3.21 | 2.90 | Upgrade
|
| P/FCF Ratio | - | 93.80 | - | - | 23.57 | - | Upgrade
|
| P/OCF Ratio | 80.50 | 30.43 | 71.39 | 345.99 | 15.48 | 63.72 | Upgrade
|
| PEG Ratio | - | 1.34 | 1.34 | 1.34 | 1.34 | 1.34 | Upgrade
|
| EV/Sales Ratio | 6.02 | 3.61 | 4.80 | 8.02 | 3.82 | 4.41 | Upgrade
|
| EV/EBITDA Ratio | 38.71 | 27.59 | 26.94 | 44.93 | 20.08 | 23.71 | Upgrade
|
| EV/EBIT Ratio | 55.55 | 43.00 | 36.19 | 56.44 | 25.22 | 32.93 | Upgrade
|
| EV/FCF Ratio | -176.42 | 81.21 | - | - | 22.71 | - | Upgrade
|
| Debt / Equity Ratio | 0.13 | 0.08 | 0.16 | 0.24 | 0.15 | 0.20 | Upgrade
|
| Debt / EBITDA Ratio | 1.41 | 0.94 | 1.55 | 1.88 | 1.11 | 2.03 | Upgrade
|
| Debt / FCF Ratio | - | 2.79 | - | - | 1.26 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.20 | -0.39 | -0.35 | -0.14 | -0.22 | -0.25 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.23 | -4.85 | -3.44 | -1.08 | -1.68 | -2.59 | Upgrade
|
| Net Debt / FCF Ratio | 10.13 | -14.27 | 9.28 | 2.53 | -1.90 | 58.98 | Upgrade
|
| Asset Turnover | 0.45 | 0.41 | 0.43 | 0.50 | 0.50 | 0.37 | Upgrade
|
| Inventory Turnover | 2.67 | 2.36 | 2.16 | 2.02 | 1.90 | 1.69 | Upgrade
|
| Quick Ratio | 3.14 | 2.43 | 3.30 | 2.39 | 4.01 | 3.17 | Upgrade
|
| Current Ratio | 3.73 | 2.88 | 3.90 | 2.92 | 5.10 | 3.82 | Upgrade
|
| Return on Equity (ROE) | -6.10% | -8.76% | 5.99% | 8.58% | 7.67% | -11.20% | Upgrade
|
| Return on Assets (ROA) | 3.02% | 2.15% | 3.54% | 4.45% | 4.75% | 3.08% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.28% | 7.70% | 9.80% | 10.76% | 11.95% | 7.50% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.10% | 4.80% | 6.40% | 8.20% | 8.40% | 6.40% | Upgrade
|
| Earnings Yield | -1.27% | -2.91% | 1.93% | 1.48% | 2.88% | -4.82% | Upgrade
|
| FCF Yield | -0.54% | 1.07% | -1.27% | -0.94% | 4.24% | -0.18% | Upgrade
|
| Dividend Yield | 1.11% | 1.67% | 1.28% | 0.77% | 1.75% | 1.96% | Upgrade
|
| Payout Ratio | - | - | 65.15% | 56.33% | 67.30% | - | Upgrade
|
| Buyback Yield / Dilution | -1.36% | -1.00% | -2.19% | -1.50% | 1.45% | 1.20% | Upgrade
|
| Total Shareholder Return | -0.25% | 0.67% | -0.90% | -0.73% | 3.20% | 3.16% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.